MML Investors Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.03M | Buy |
18,651
+7,311
| +64% | +$1.4M | 0.01% | 1112 |
|
|
2026
Q1 | $2.08M | Buy |
11,340
+3,115
| +38% | +$574K | 0.01% | 1298 |
|
|
2025
Q4 | $1.45M | Buy |
8,225
+939
| +13% | +$153K | ﹤0.01% | 1574 |
|
|
2025
Q3 | $1.02M | Sell |
7,286
-1,274
| -15% | -$172K | ﹤0.01% | 1711 |
|
|
2025
Q2 | $1.07M | Buy |
8,560
+617
| +8% | +$76.9K | ﹤0.01% | 1617 |
|
|
2025
Q1 | $1.09M | Buy |
7,943
+428
| +6% | +$61.2K | ﹤0.01% | 1511 |
|
|
2024
Q4 | $1.15M | Sell |
7,515
-2,765
| -27% | -$466K | ﹤0.01% | 1416 |
|
|
2024
Q3 | $1.99M | Buy |
10,280
+380
| +4% | +$79.5K | 0.01% | 1094 |
|
|
2024
Q2 | $2.29M | Buy |
9,900
+58
| +0.6% | +$12.6K | 0.01% | 974 |
|
|
2024
Q1 | $2.12M | Sell |
9,842
-1,017
| -9% | -$238K | 0.01% | 1021 |
|
|
2023
Q4 | $2.81M | Buy |
10,859
+470
| +5% | +$115K | 0.01% | 850 |
|
|
2023
Q3 | $2.67M | Sell |
10,389
-563
| -5% | -$151K | 0.01% | 773 |
|
|
2023
Q2 | $3.12M | Buy |
10,952
+4,118
| +60% | +$1.23M | 0.02% | 709 |
|
|
2023
Q1 | $1.9M | Sell |
6,834
-1,082
| -14% | -$299K | 0.01% | 800 |
|
|
2022
Q4 | $2.19M | Buy |
7,916
+1,091
| +16% | +$308K | 0.01% | 791 |
|
|
2022
Q3 | $1.82M | Sell |
6,825
-122
| -2% | -$25.9K | 0.01% | 791 |
|
|
2022
Q2 | $1.42M | Buy |
6,947
+1,210
| +21% | +$247K | 0.01% | 885 |
|
|
2022
Q1 | $1.21M | Sell |
5,737
-6,576
| -53% | -$1.43M | 0.01% | 1005 |
|
|
2021
Q4 | $2.95M | Sell |
12,313
-705
| -5% | -$181K | 0.02% | 603 |
|
|
2021
Q3 | $3.68M | Buy |
13,018
+2,548
| +24% | +$835K | 0.03% | 509 |
|
|
2021
Q2 | $3.63M | Sell |
10,470
-1,854
| -15% | -$562K | 0.03% | 488 |
|
|
2021
Q1 | $3.45M | Sell |
12,324
-22
| -0.2% | -$5.93K | 0.03% | 462 |
|
|
2020
Q4 | $3.02M | Buy |
12,346
+2,352
| +24% | +$607K | 0.03% | 449 |
|
|
2020
Q3 | $2.83M | Buy |
9,994
+924
| +10% | +$258K | 0.04% | 407 |
|
|
2020
Q2 | $2.43M | Buy |
9,070
+813
| +10% | +$244K | 0.03% | 434 |
|
|
2020
Q1 | $2.61M | Sell |
8,257
-914
| -10% | -$277K | 0.04% | 341 |
|
|
2019
Q4 | $2.72M | Buy |
9,171
+887
| +11% | +$246K | 0.04% | 397 |
|
|
2019
Q3 | $1.93M | Sell |
8,284
-1,795
| -18% | -$418K | 0.03% | 449 |
|
|
2019
Q2 | $2.36M | Sell |
10,079
-1,018
| -9% | -$235K | 0.03% | 435 |
|
|
2019
Q1 | $2.62M | Buy |
11,097
+3,407
| +44% | +$1.07M | 0.04% | 375 |
|
|
2018
Q4 | $2.31M | Buy |
7,690
+1,054
| +16% | +$336K | 0.04% | 376 |
|
|
2018
Q3 | $2.35M | Buy |
6,636
+3,621
| +120% | +$1.25M | 0.04% | 397 |
|
|
2018
Q2 | $875K | Sell |
3,015
-349
| -10% | -$98.1K | 0.02% | 615 |
|
|
2018
Q1 | $921K | Sell |
3,364
-235
| -7% | -$72.9K | 0.02% | 571 |
|
|
2017
Q4 | $1.15M | Sell |
3,599
-175
| -5% | -$56.1K | 0.02% | 499 |
|
|
2017
Q3 | $1.18M | Sell |
3,774
-6
| -0.2% | -$1.78K | 0.02% | 454 |
|
|
2017
Q2 | $1.03M | Buy |
3,780
+41
| +1% | +$10.8K | 0.02% | 503 |
|
|
2017
Q1 | $1.02M | Buy |
+3,739
| New | +$1.06M | 0.02% | 271 |
|
Other funds holding BIIB
AIM
MML Investors Services's BIIB Position: Q2 2026 in Review
MML Investors Services increased its Biogen (BIIB) stake by 64% in Q2 2026, buying an estimated $1.4M and bringing the position to 18,651 shares worth $4.03M. The position accounts for 0.01% of the portfolio, ranked #1112.
MML Investors Services first reported a position in BIIB in Q1 2017 and has held it in 38 quarters since. 621 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- MML Investors Services held 18,651 shares of Biogen worth $4.03M as of Q2 2026.
- MML Investors Services bought 7,311 Biogen shares in Q2 2026, an estimated $1.4M.
- Biogen made up 0.01% of MML Investors Services's portfolio in Q2 2026, its #1112 holding.
- MML Investors Services first reported a position in Biogen in Q1 2017 and has held it in 38 quarters since.
- 621 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.